Remove Best Practices Remove Cardiovascular Disease Remove Innovation
article thumbnail

CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

DAIC

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.

article thumbnail

Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association

Circulation: Genomic and Precision Medicine

This requires an interoperability framework that enables the deployment of platforms, sensors, devices, and software applications within diverse health systems, aiming to facilitate innovation in preventing and treating cardiovascular disease.

article thumbnail

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

DAIC

Within the complex umbrella of cardiovascular disease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.

article thumbnail

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

Cardiovascular Update for the Clinician: A Symposium by Valentin Fuster” will offer the latest advances in the treatment of cardiovascular disease and ways to integrate them into daily practice. This includes a review of updated clinical guidelines and best practices. 24 news here.

Education 105
article thumbnail

3 Use Cases of EHR Software Reporting in Cardiology Clinics

GEMMS

These EHR reporting tools enable risk stratification, allowing clinicians to identify patients at high risk for cardiovascular diseases through comprehensive data analysis. Clinicians can compare patient outcomes, treatments, and interventions with the broader cardiology population, enabling evidence-based decision-making.